$NLNK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LUMOS PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in LUMOS PHARMA, INC.. Get notifications about new insider transactions in LUMOS PHARMA, INC. for free.
Page: < prev 1 2 3 4 5 6 7 ... 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 12 2018 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | M | 2.10 | 3,093 | 6,495 | 0 | |
| Jul 12 2018 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | M | 2.10 | 3,571 | 7,499 | 0 | |
| Jul 12 2018 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | M | 2.10 | 7,142 | 14,998 | 0 | |
| Jul 12 2018 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Sell | S | 4.82 | 13,806 | 66,600 | 32,223 | 46 K to 32.2 K (-29.99 %) |
| Jul 12 2018 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Buy | M | 2.10 | 3,093 | 6,495 | 46,029 | 42.9 K to 46 K (+7.20 %) |
| Jul 12 2018 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Buy | M | 2.10 | 3,571 | 7,499 | 42,936 | 39.4 K to 42.9 K (+9.07 %) |
| Jul 12 2018 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Buy | M | 2.10 | 7,142 | 14,998 | 39,365 | 32.2 K to 39.4 K (+22.16 %) |
| May 25 2018 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 5.33 | 27,777 | 148,051 | 27,777 | |
| May 25 2018 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 5.33 | 27,777 | 148,051 | 27,777 | |
| May 25 2018 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 5.33 | 27,777 | 148,051 | 27,777 | |
| May 25 2018 | NLNK | NEWLINK GENETICS C ... | Sherman Matthew L | Director | Option Exercise | A | 5.33 | 27,777 | 148,051 | 27,777 | |
| May 25 2018 | NLNK | NEWLINK GENETICS C ... | Pucci Paolo | Director | Option Exercise | A | 5.33 | 27,777 | 148,051 | 27,777 | |
| May 25 2018 | NLNK | NEWLINK GENETICS C ... | JOHNSON CHAD ALLEN | Director | Option Exercise | A | 5.33 | 27,777 | 148,051 | 27,777 | |
| Mar 13 2018 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Option Exercise | A | 7.85 | 126,500 | 993,025 | 126,500 | |
| Mar 13 2018 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 7.85 | 110,000 | 863,500 | 110,000 | |
| Mar 13 2018 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Option Exercise | A | 7.85 | 55,000 | 431,750 | 55,000 | |
| Mar 13 2018 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Option Exercise | A | 7.85 | 122,000 | 957,700 | 122,000 | |
| Mar 13 2018 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Option Exercise | A | 7.85 | 310,000 | 2,433,500 | 310,000 | |
| Mar 13 2018 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | Chief Commercial Of ... | Option Exercise | A | 7.85 | 110,000 | 863,500 | 110,000 | |
| Jan 23 2018 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Payment of Exercise | F | 8.62 | 85 | 733 | 13,892 | 14 K to 13.9 K (-0.61 %) |
| Jan 05 2018 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Payment of Exercise | F | 10.06 | 409 | 4,115 | 13,977 | 14.4 K to 14 K (-2.84 %) |
| Jan 04 2018 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Payment of Exercise | F | 10.06 | 1,323 | 13,309 | 57,536 | 58.9 K to 57.5 K (-2.25 %) |
| Jan 04 2018 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Payment of Exercise | F | 8.47 | 164 | 1,389 | 58,859 | 59 K to 58.9 K (-0.28 %) |
| Jan 04 2018 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Payment of Exercise | F | 10.06 | 257 | 2,585 | 18,905 | 19.2 K to 18.9 K (-1.34 %) |
| Jan 04 2018 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Payment of Exercise | F | 8.47 | 883 | 7,479 | 19,162 | 20 K to 19.2 K (-4.41 %) |
| Jan 04 2018 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Payment of Exercise | F | 10.06 | 5,541 | 55,742 | 259,842 | 265.4 K to 259.8 K (-2.09 %) |
| Jan 04 2018 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Payment of Exercise | F | 8.47 | 8,939 | 75,713 | 265,383 | 274.3 K to 265.4 K (-3.26 %) |
| Jan 04 2018 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | Chief Commercial Of ... | Payment of Exercise | F | 10.06 | 603 | 6,066 | 18,150 | 18.8 K to 18.2 K (-3.22 %) |
| Jan 04 2018 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | Chief Commercial Of ... | Payment of Exercise | F | 8.47 | 1,237 | 10,477 | 18,753 | 20 K to 18.8 K (-6.19 %) |
| Jan 04 2018 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Payment of Exercise | F | 10.06 | 2,659 | 26,750 | 53,408 | 56.1 K to 53.4 K (-4.74 %) |
| Jan 04 2018 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Payment of Exercise | F | 8.47 | 3,866 | 32,745 | 56,067 | 59.9 K to 56.1 K (-6.45 %) |
| Nov 22 2017 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Option Exercise | M | 2.10 | 9,523 | 19,998 | 0 | |
| Nov 22 2017 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Sell | S | 9.05 | 2,229 | 20,172 | 19,666 | 21.9 K to 19.7 K (-10.18 %) |
| Nov 22 2017 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Buy | M | 2.10 | 9,523 | 19,998 | 21,895 | 12.4 K to 21.9 K (+76.97 %) |
| Oct 06 2017 | NLNK | NEWLINK GENETICS C ... | Stine Seed Farm, Inc. | 10% Owner | Buy | P | 10.25 | 780,487 | 7,999,992 | 7,857,732 | 7.1 M to 7.9 M (+11.03 %) |
| Oct 02 2017 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Payment of Exercise | F | 10.18 | 2,789 | 28,392 | 56,544 | 59.3 K to 56.5 K (-4.70 %) |
| May 16 2017 | NLNK | NEWLINK GENETICS C ... | Pucci Paolo | Director | Option Exercise | A | 17.42 | 13,309 | 231,843 | 13,309 | |
| May 16 2017 | NLNK | NEWLINK GENETICS C ... | Saluri Joseph | Director | Option Exercise | A | 17.42 | 13,309 | 231,843 | 13,309 | |
| May 16 2017 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 17.42 | 13,309 | 231,843 | 13,309 | |
| May 16 2017 | NLNK | NEWLINK GENETICS C ... | Edick Paul R | Director | Option Exercise | A | 17.42 | 13,309 | 231,843 | 13,309 | |
| May 16 2017 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 17.42 | 13,309 | 231,843 | 13,309 | |
| May 16 2017 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 17.42 | 13,309 | 231,843 | 13,309 | |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Option Exercise | A | 10.55 | 326,288 | 3,442,338 | 326,288 | |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Payment of Exercise | F | 11.04 | 3,169 | 34,986 | 274,322 | 277.5 K to 274.3 K (-1.14 %) |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Payment of Exercise | F | 10.28 | 5,265 | 54,124 | 277,491 | 282.8 K to 277.5 K (-1.86 %) |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | Chief Commercial Of ... | Option Exercise | A | 10.55 | 75,000 | 791,250 | 75,000 | |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | Chief Commercial Of ... | Payment of Exercise | F | 11.04 | 603 | 6,657 | 19,271 | 19.9 K to 19.3 K (-3.03 %) |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | Chief Commercial Of ... | Payment of Exercise | F | 10.28 | 1,237 | 12,716 | 19,874 | 21.1 K to 19.9 K (-5.86 %) |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Option Exercise | A | 10.55 | 137,500 | 1,450,625 | 137,500 | |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Payment of Exercise | F | 11.04 | 1,323 | 14,606 | 58,612 | 59.9 K to 58.6 K (-2.21 %) |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Payment of Exercise | F | 10.28 | 164 | 1,686 | 59,935 | 60.1 K to 59.9 K (-0.27 %) |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Option Exercise | A | 10.55 | 37,500 | 395,625 | 37,500 | |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Payment of Exercise | F | 11.04 | 257 | 2,837 | 9,551 | 9.8 K to 9.6 K (-2.62 %) |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Payment of Exercise | F | 10.28 | 883 | 9,077 | 9,808 | 10.7 K to 9.8 K (-8.26 %) |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Option Exercise | A | 10.55 | 312,500 | 3,296,875 | 312,500 | |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Payment of Exercise | F | 11.04 | 2,085 | 23,018 | 59,933 | 62 K to 59.9 K (-3.36 %) |
| Jan 05 2017 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Payment of Exercise | F | 10.28 | 3,266 | 33,574 | 62,018 | 65.3 K to 62 K (-5.00 %) |
| Dec 16 2016 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Sell | S | 10.85 | 3,943 | 42,782 | 10,691 | 14.6 K to 10.7 K (-26.94 %) |
| Oct 04 2016 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Payment of Exercise | F | 15.02 | 2,789 | 41,891 | 60,099 | 62.9 K to 60.1 K (-4.43 %) |
| Aug 11 2016 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 10.78 | 4,782 | 51,550 | 4,782 | |
| Aug 11 2016 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 10.78 | 17,774 | 191,604 | 17,774 | |
| Aug 11 2016 | NLNK | NEWLINK GENETICS C ... | Saluri Joseph | Director | Option Exercise | A | 10.78 | 4,783 | 51,561 | 4,783 | |
| Aug 11 2016 | NLNK | NEWLINK GENETICS C ... | Saluri Joseph | Director | Option Exercise | A | 10.78 | 17,773 | 191,593 | 17,773 | |
| Aug 11 2016 | NLNK | NEWLINK GENETICS C ... | Pucci Paolo | Director | Option Exercise | A | 10.78 | 4,783 | 51,561 | 4,783 | |
| Aug 11 2016 | NLNK | NEWLINK GENETICS C ... | Pucci Paolo | Director | Option Exercise | A | 10.78 | 17,773 | 191,593 | 17,773 | |
| Aug 11 2016 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Option Exercise | A | 10.78 | 20,000 | 215,600 | 20,000 | |
| Aug 11 2016 | NLNK | NEWLINK GENETICS C ... | Edick Paul R | Director | Option Exercise | A | 10.78 | 4,783 | 51,561 | 4,783 | |
| Aug 11 2016 | NLNK | NEWLINK GENETICS C ... | Edick Paul R | Director | Option Exercise | A | 10.78 | 17,773 | 191,593 | 17,773 | |
| Aug 11 2016 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 10.78 | 4,783 | 51,561 | 4,783 | |
| Aug 11 2016 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 10.78 | 17,773 | 191,593 | 17,773 | |
| Aug 11 2016 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Option Exercise | A | 10.78 | 150,000 | 1,617,000 | 150,000 | |
| Aug 11 2016 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | Chief Commercial Of ... | Option Exercise | A | 10.78 | 30,000 | 323,400 | 30,000 | |
| Aug 11 2016 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 10.78 | 4,782 | 51,550 | 4,782 | |
| Aug 11 2016 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 10.78 | 17,774 | 191,604 | 17,774 | |
| Jun 08 2016 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Buy | P | 12.32 | 4,065 | 50,081 | 32,223 | 28.2 K to 32.2 K (+14.44 %) |
| Mar 16 2016 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 18.60 | 5,000 | 93,000 | 292,756 | 297.8 K to 292.8 K (-1.68 %) |
| Mar 16 2016 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 17.68 | 20,000 | 353,600 | 297,756 | 317.8 K to 297.8 K (-6.29 %) |
| Feb 04 2016 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 24.46 | 13,500 | 330,210 | 317,756 | 331.3 K to 317.8 K (-4.08 %) |
| Feb 04 2016 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 23.81 | 11,500 | 273,815 | 331,256 | 342.8 K to 331.3 K (-3.36 %) |
| Apr 11 2016 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 20.03 | 10,000 | 200,250 | 282,756 | 292.8 K to 282.8 K (-3.42 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Option Exercise | A | 34.73 | 46,351 | 1,609,770 | 46,351 | |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Sell | S | 35.74 | 175 | 6,255 | 62,316 | 62.5 K to 62.3 K (-0.28 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Grant | A | 0.00 | 16,201 | 0 | 62,491 | 46.3 K to 62.5 K (+35.00 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Option Exercise | A | 34.73 | 8,989 | 312,188 | 8,989 | |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Sell | S | 35.42 | 500 | 17,710 | 13,465 | 14 K to 13.5 K (-3.58 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Sell | S | 34.60 | 595 | 20,587 | 13,965 | 14.6 K to 14 K (-4.09 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Grant | A | 0.00 | 3,142 | 0 | 14,560 | 11.4 K to 14.6 K (+27.52 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Option Exercise | A | 34.73 | 18,259 | 634,135 | 18,259 | |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 35.20 | 1,000 | 35,200 | 19,942 | 20.9 K to 19.9 K (-4.78 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 34.26 | 295 | 10,107 | 20,942 | 21.2 K to 20.9 K (-1.39 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Grant | A | 0.00 | 6,382 | 0 | 21,237 | 14.9 K to 21.2 K (+42.96 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Option Exercise | A | 34.73 | 133,435 | 4,634,198 | 133,435 | |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 33.06 | 7,900 | 261,174 | 342,756 | 350.7 K to 342.8 K (-2.25 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 32.29 | 17,100 | 552,159 | 350,656 | 367.8 K to 350.7 K (-4.65 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 35.29 | 3,621 | 127,785 | 367,756 | 371.4 K to 367.8 K (-0.98 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 34.46 | 1,380 | 47,555 | 371,377 | 372.8 K to 371.4 K (-0.37 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Grant | A | 0.00 | 46,639 | 0 | 372,757 | 326.1 K to 372.8 K (+14.30 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Option Exercise | A | 34.73 | 84,275 | 2,926,871 | 84,275 | |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Sell | S | 35.57 | 1,000 | 35,570 | 65,284 | 66.3 K to 65.3 K (-1.51 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Sell | S | 34.80 | 2,011 | 69,983 | 66,284 | 68.3 K to 66.3 K (-2.94 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Grant | A | 0.00 | 29,456 | 0 | 68,295 | 38.8 K to 68.3 K (+75.84 %) |
| Dec 04 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 38.30 | 7,500 | 287,250 | 326,118 | 333.6 K to 326.1 K (-2.25 %) |
| Dec 04 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 36.50 | 1,095 | 39,968 | 333,618 | 334.7 K to 333.6 K (-0.33 %) |
| Dec 04 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 35.13 | 16,405 | 576,308 | 334,713 | 351.1 K to 334.7 K (-4.67 %) |
| Nov 06 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 43.83 | 5,000 | 219,150 | 351,118 | 356.1 K to 351.1 K (-1.40 %) |
| Nov 06 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 42.55 | 5,000 | 212,750 | 356,118 | 361.1 K to 356.1 K (-1.38 %) |
| Nov 06 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 40.29 | 10,000 | 402,900 | 361,118 | 371.1 K to 361.1 K (-2.69 %) |
| Oct 07 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 35.16 | 10,000 | 351,600 | 371,118 | 381.1 K to 371.1 K (-2.62 %) |
| Oct 07 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 38.17 | 5,000 | 190,850 | 381,118 | 386.1 K to 381.1 K (-1.29 %) |
| Oct 07 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 36.96 | 10,000 | 369,600 | 386,118 | 396.1 K to 386.1 K (-2.52 %) |
| Oct 05 2015 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Payment of Exercise | F | 35.32 | 4,199 | 148,309 | 46,290 | 50.5 K to 46.3 K (-8.32 %) |
| Sep 15 2015 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Option Exercise | M | 2.10 | 10,000 | 21,000 | 204,895 | |
| Sep 15 2015 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Sell | S | 51.19 | 10,000 | 511,882 | 38,839 | 48.8 K to 38.8 K (-20.48 %) |
| Sep 15 2015 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Buy | M | 2.10 | 10,000 | 21,000 | 48,839 | 38.8 K to 48.8 K (+25.75 %) |
| Sep 08 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 44.87 | 12,500 | 560,875 | 396,118 | 408.6 K to 396.1 K (-3.06 %) |
| Sep 08 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 45.92 | 2,500 | 114,800 | 408,618 | 411.1 K to 408.6 K (-0.61 %) |
| Sep 08 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 44.75 | 5,000 | 223,750 | 411,118 | 416.1 K to 411.1 K (-1.20 %) |
| Sep 08 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Gift | G | 0.00 | 15,000 | 0 | 25,000 | 10 K to 25 K (+150.00 %) |
| Sep 08 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Gift | G | 0.00 | 15,000 | 0 | 416,118 | 431.1 K to 416.1 K (-3.48 %) |
| Aug 07 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 52.68 | 4,990 | 262,873 | 431,118 | 436.1 K to 431.1 K (-1.14 %) |
| Aug 07 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 51.92 | 15,010 | 779,319 | 436,108 | 451.1 K to 436.1 K (-3.33 %) |
| Aug 04 2015 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Option Exercise | M | 2.10 | 10,000 | 21,000 | 214,895 | |
| Aug 04 2015 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Sell | S | 51.77 | 10,000 | 517,700 | 38,839 | 48.8 K to 38.8 K (-20.48 %) |
| Aug 04 2015 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Buy | M | 2.10 | 10,000 | 21,000 | 48,839 | 38.8 K to 48.8 K (+25.75 %) |
| Jul 16 2015 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Option Exercise | M | 2.10 | 20,000 | 42,000 | 224,895 | |
| Jul 16 2015 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Sell | S | 51.14 | 20,000 | 1,022,800 | 38,839 | 58.8 K to 38.8 K (-33.99 %) |
| Jul 16 2015 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Buy | M | 2.10 | 20,000 | 42,000 | 58,839 | 38.8 K to 58.8 K (+51.49 %) |
| Jul 15 2015 | NLNK | NEWLINK GENETICS C ... | Saluri Joseph | Director | Option Exercise | M | 3.07 | 2,500 | 7,675 | 9,404 | |
| Jul 15 2015 | NLNK | NEWLINK GENETICS C ... | Saluri Joseph | Director | Option Exercise | M | 13.30 | 2,500 | 33,250 | 9,402 | |
| Jul 15 2015 | NLNK | NEWLINK GENETICS C ... | Saluri Joseph | Director | Sell | S | 50.42 | 5,000 | 252,100 | 16,048 | 21 K to 16 K (-23.76 %) |
| Jul 15 2015 | NLNK | NEWLINK GENETICS C ... | Saluri Joseph | Director | Buy | M | 3.07 | 2,500 | 7,675 | 21,048 | 18.5 K to 21 K (+13.48 %) |
| Jul 15 2015 | NLNK | NEWLINK GENETICS C ... | Saluri Joseph | Director | Buy | M | 13.30 | 2,500 | 33,250 | 18,548 | 16 K to 18.5 K (+15.58 %) |
| Jul 08 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 45.55 | 5,000 | 227,750 | 451,118 | 456.1 K to 451.1 K (-1.10 %) |
| Jul 08 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 44.97 | 7,500 | 337,275 | 456,118 | 463.6 K to 456.1 K (-1.62 %) |
| Jul 08 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 43.72 | 7,500 | 327,900 | 463,618 | 471.1 K to 463.6 K (-1.59 %) |
| Jun 18 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 45.19 | 5,000 | 225,950 | 471,118 | 476.1 K to 471.1 K (-1.05 %) |
| Jun 18 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 44.29 | 15,000 | 664,350 | 476,118 | 491.1 K to 476.1 K (-3.05 %) |
| Jun 04 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 44.90 | 10,000 | 449,000 | 491,118 | 501.1 K to 491.1 K (-2.00 %) |
| Jun 04 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 44.28 | 10,000 | 442,800 | 501,118 | 511.1 K to 501.1 K (-1.96 %) |
| Jun 03 2015 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Option Exercise | M | 21.38 | 280 | 5,986 | 31,970 | |
| Jun 03 2015 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Option Exercise | M | 11.79 | 2,200 | 25,938 | 15,645 | |
| Jun 03 2015 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Sell | S | 42.94 | 1,000 | 42,940 | 32,146 | 33.1 K to 32.1 K (-3.02 %) |
| Jun 03 2015 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Sell | S | 42.53 | 1,500 | 63,795 | 33,146 | 34.6 K to 33.1 K (-4.33 %) |
| Jun 03 2015 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Buy | M | 21.38 | 280 | 5,986 | 34,646 | 34.4 K to 34.6 K (+0.81 %) |
| Jun 03 2015 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Buy | M | 11.79 | 2,200 | 25,938 | 34,366 | 32.2 K to 34.4 K (+6.84 %) |
| May 14 2015 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Buy | P | 37.30 | 3,000 | 111,900 | 50,489 | 47.5 K to 50.5 K (+6.32 %) |
| May 14 2015 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Gift | G | 0.00 | 300 | 0 | 47,489 | 47.8 K to 47.5 K (-0.63 %) |
| May 08 2015 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Option Exercise | M | 11.79 | 5,000 | 58,950 | 17,845 | |
| May 08 2015 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Sell | S | 50.00 | 5,000 | 250,000 | 41,667 | 46.7 K to 41.7 K (-10.71 %) |
| May 08 2015 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Buy | M | 11.79 | 5,000 | 58,950 | 46,667 | 41.7 K to 46.7 K (+12.00 %) |